Silverback Therapeutics Inc (SBTX)

Healthcare Pharmaceuticals & Medical Research Biotechnology & Medical Research

Track Share on 𝕏

Stock chart
Ticker: SBTX Exchange: NMS


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale
Earnings
 
Value bought

Past 90 days

 
Value sold

Past 90 days

 
Net insiders buying

Past 90 days

 
Trades (buy and sell)

Past 90 days

Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2025-01-07 2025-01-06 PS Planned sale

Shawver Laura

Non-Executive Director
1,000 -19.2%
11.10
USD 555,065 		1,000 -19.2% 11.10 USD 100,000
2024-12-19 2024-12-17 PS Planned sale

Tanimoto Sarina

CHIEF MEDICAL OFFICER

Officer Large shareholder
50,000 -4.4%
11.67
USD 583,525 		50,000 -4.4% 11.67 USD 583,525
2024-12-19 2024-12-17 PS Planned sale

Tanimoto Sarina

CHIEF MEDICAL OFFICER

Officer Large shareholder
50,000 -3.7%
11.67
USD 583,575 		50,000 -3.7% 11.67 USD 583,575
2024-12-19 2024-12-17 PS Planned sale

Lowenthal Richard E

PRESIDENT AND CEO

Executive Director Large shareholder
50,000 -4.4%
11.67
USD 583,525 		50,000 -4.4% 11.67 USD 583,525
2024-12-19 2024-12-17 PS Planned sale

Lowenthal Richard E

PRESIDENT AND CEO

Executive Director Large shareholder
50,000 -3.7%
11.67
USD 583,575 		50,000 -3.7% 11.67 USD 583,575
2024-12-13 2024-12-13 S Sale

Chakma Justin

Chief Business Officer

Officer
27,272 -16.7%
12.06
USD 328,969 		27,272 -16.7% 12.06 USD 328,969
2024-12-13 2024-12-12 S Sale

Dorsey Brian

Chief Operating Officer

Officer
25,000 -80.6%
12.30
USD 307,433 		25,000 -80.6% 12.30 USD 307,433
2024-12-13 2024-12-12 S Sale

Chakma Justin

Chief Business Officer

Officer
117,333 -46.2%
12.27
USD 1,439,124 		117,333 -46.2% 12.27 USD 1,439,124
2024-12-13 2024-12-11 PS Planned sale

Dorsey Brian

Chief Operating Officer

Officer
15,000 -71.3%
12.43
USD 186,426 		15,000 -71.3% 12.43 USD 186,426
2024-12-12 2024-12-10 S Sale

Chakma Justin

Chief Business Officer

Officer
50,000 -26.8%
13.15
USD 657,625 		50,000 -26.8% 13.15 USD 657,625
2024-12-11 2024-12-10 PS Planned sale

Tanimoto Sarina

CHIEF MEDICAL OFFICER

Officer Large shareholder
50,000 -4.2%
13.16
USD 658,155 		50,000 -4.2% 13.16 USD 658,155
2024-12-11 2024-12-10 PS Planned sale

Tanimoto Sarina

CHIEF MEDICAL OFFICER

Officer Large shareholder
50,000 -3.9%
13.17
USD 658,265 		50,000 -3.9% 13.17 USD 658,265
2024-12-11 2024-12-10 PS Planned sale

Lowenthal Richard E

PRESIDENT AND CEO

Executive Director Large shareholder
50,000 -4.2%
13.16
USD 658,155 		50,000 -4.2% 13.16 USD 658,155
2024-12-11 2024-12-10 PS Planned sale

Lowenthal Richard E

PRESIDENT AND CEO

Executive Director Large shareholder
50,000 -3.9%
13.17
USD 658,265 		50,000 -3.9% 13.17 USD 658,265
2024-12-06 2024-12-06 S Sale

Chakma Justin

Chief Business Officer

Officer
50,000 -26.8%
14.23
USD 711,615 		50,000 -26.8% 14.23 USD 711,615
2024-12-06 2024-12-05 S Sale

Chakma Justin

Chief Business Officer

Officer
49,640 -26.7%
14.13
USD 701,642 		49,640 -26.7% 14.13 USD 701,642
2024-12-06 2024-12-04 S Sale

Chakma Justin

Chief Business Officer

Officer
45,000 -24.8%
13.95
USD 627,944 		45,000 -24.8% 13.95 USD 627,944
2024-12-04 2024-12-04 PS Planned sale

Shawver Laura

Non-Executive Director
14,772 -6.6%
13.75
USD 203,109 		14,772 -6.6% 13.75 USD 203,109
2024-12-04 2024-12-04 PS Planned sale

Karas Eric

Chief Commercial Officer

Officer
6,283 -52.5%
14.00
USD 87,962 		6,283 -52.5% 14.00 USD 87,962
2024-12-04 2024-12-03 PS Planned sale

Shawver Laura

Non-Executive Director
87,984 -29.5%
13.26
USD 1,166,897 		87,984 -29.5% 13.26 USD 1,166,897
2024-12-04 2024-12-03 S Sale

Chakma Justin

Chief Business Officer

Officer
45,000 -24.8%
13.19
USD 593,402 		45,000 -24.8% 13.19 USD 593,402
2024-12-04 2024-12-02 PS Planned sale

Shawver Laura

Non-Executive Director
901 -0.4%
14.34
USD 12,922 		901 -0.4% 14.34 USD 12,922
2024-12-04 2024-12-02 PS Planned sale

Shawver Laura

Non-Executive Director
96,343 -31.3%
13.55
USD 1,305,823 		96,343 -31.3% 13.55 USD 1,305,823
2024-12-04 2024-12-02 PS Planned sale

Karas Eric

Chief Commercial Officer

Officer
3,717 -39.5%
14.11
USD 52,461 		3,717 -39.5% 14.11 USD 52,461
2024-12-04 2024-12-02 S Sale

Chakma Justin

Chief Business Officer

Officer
45,000 -24.8%
13.67
USD 615,218 		45,000 -24.8% 13.67 USD 615,218
2024-11-27 2024-11-27 S Sale

Chakma Justin

Chief Business Officer

Officer
25,000 -15.5%
14.39
USD 359,750 		25,000 -15.5% 14.39 USD 359,750
2024-11-27 2024-11-26 S Sale

Chakma Justin

Chief Business Officer

Officer
42,186 -20.7%
14.05
USD 592,570 		42,186 -20.7% 14.05 USD 592,570
2024-11-27 2024-11-25 S Sale

Chakma Justin

Chief Business Officer

Officer
32,814 -13.9%
14.00
USD 459,422 		32,814 -13.9% 14.00 USD 459,422
2024-11-21 2024-11-19 PS Planned sale

Lowenthal Richard E

PRESIDENT AND CEO

Executive Director Large shareholder
50,000 -4.0%
13.95
USD 697,450 		50,000 -4.0% 13.95 USD 697,450
2024-11-21 2024-11-19 PS Planned sale

Lowenthal Richard E

PRESIDENT AND CEO

Executive Director Large shareholder
50,000 -3.6%
13.95
USD 697,510 		50,000 -3.6% 13.95 USD 697,510
2024-11-21 2024-11-19 PS Planned sale

Tanimoto Sarina

CHIEF MEDICAL OFFICER

Officer Large shareholder
50,000 -4.0%
13.95
USD 697,450 		50,000 -4.0% 13.95 USD 697,450
2024-11-21 2024-11-19 PS Planned sale

Tanimoto Sarina

CHIEF MEDICAL OFFICER

Officer Large shareholder
50,000 -3.6%
13.95
USD 697,510 		50,000 -3.6% 13.95 USD 697,510
2024-11-14 2024-11-12 PS Planned sale

Tanimoto Sarina

CHIEF MEDICAL OFFICER

Officer Large shareholder
4,876 -0.4%
17.64
USD 86,020 		4,876 -0.4% 17.64 USD 86,020
2024-11-14 2024-11-12 PS Planned sale

Tanimoto Sarina

CHIEF MEDICAL OFFICER

Officer Large shareholder
45,124 -3.5%
16.76
USD 756,296 		45,124 -3.5% 16.76 USD 756,296
2024-11-14 2024-11-12 PS Planned sale

Tanimoto Sarina

CHIEF MEDICAL OFFICER

Officer Large shareholder
4,955 -0.4%
17.64
USD 87,421 		4,955 -0.4% 17.64 USD 87,421
2024-11-14 2024-11-12 PS Planned sale

Tanimoto Sarina

CHIEF MEDICAL OFFICER

Officer Large shareholder
45,045 -3.3%
16.76
USD 754,905 		45,045 -3.3% 16.76 USD 754,905
2024-11-14 2024-11-12 PS Planned sale

Lowenthal Richard E

PRESIDENT AND CEO

Executive Director Large shareholder
4,876 -0.4%
17.64
USD 86,020 		4,876 -0.4% 17.64 USD 86,020
2024-11-14 2024-11-12 PS Planned sale

Lowenthal Richard E

PRESIDENT AND CEO

Executive Director Large shareholder
45,124 -3.5%
16.76
USD 756,296 		45,124 -3.5% 16.76 USD 756,296
2024-11-14 2024-11-12 PS Planned sale

Lowenthal Richard E

PRESIDENT AND CEO

Executive Director Large shareholder
4,955 -0.4%
17.64
USD 87,421 		4,955 -0.4% 17.64 USD 87,421
2024-11-14 2024-11-12 PS Planned sale

Lowenthal Richard E

PRESIDENT AND CEO

Executive Director Large shareholder
45,045 -3.3%
16.76
USD 754,905 		45,045 -3.3% 16.76 USD 754,905
2024-11-13 2024-11-12 S Sale

Flynn James E

Large shareholder
9,553 -0.2%
17.77
USD 169,757 		9,553 -0.2% 17.77 USD 169,757
2024-11-13 2024-11-12 S Sale

Flynn James E

Large shareholder
9,554 -0.2%
17.77
USD 169,775 		9,554 -0.2% 17.77 USD 169,775
2024-11-13 2024-11-12 S Sale

Flynn James E

Large shareholder
7,854 -0.1%
17.16
USD 134,775 		7,854 -0.1% 17.16 USD 134,775
2024-11-13 2024-11-12 S Sale

Flynn James E

Large shareholder
7,853 -0.1%
17.16
USD 134,757 		7,853 -0.1% 17.16 USD 134,757
2024-11-13 2024-11-11 S Sale

Flynn James E

Large shareholder
223,632 -4.1%
18.15
USD 4,058,921 		223,632 -4.1% 18.15 USD 4,058,921
2024-11-13 2024-11-11 S Sale

Flynn James E

Large shareholder
223,632 -4.1%
18.15
USD 4,058,921 		223,632 -4.1% 18.15 USD 4,058,921
2024-11-13 2024-11-11 S Sale

Flynn James E

Large shareholder
40,596 -0.7%
17.45
USD 708,400 		40,596 -0.7% 17.45 USD 708,400
2024-11-13 2024-11-11 S Sale

Flynn James E

Large shareholder
40,596 -0.7%
17.45
USD 708,400 		40,596 -0.7% 17.45 USD 708,400
2024-10-17 2024-10-16 PS Planned sale

Scott Kathleen D.

Chief Financial Officer

Officer
12,500 -71.6%
16.00
USD 200,000 		12,500 -71.6% 16.00 USD 200,000
2024-10-17 2024-10-15 PS Planned sale

Lowenthal Richard E

PRESIDENT AND CEO

Executive Director Large shareholder
50,000 -3.7%
14.88
USD 743,820 		50,000 -3.7% 14.88 USD 743,820
2024-10-17 2024-10-15 PS Planned sale

Lowenthal Richard E

PRESIDENT AND CEO

Executive Director Large shareholder
1,450 -0.1%
15.25
USD 22,118 		1,450 -0.1% 15.25 USD 22,118
2024-10-17 2024-10-15 PS Planned sale

Lowenthal Richard E

PRESIDENT AND CEO

Executive Director Large shareholder
48,550 -3.4%
14.86
USD 721,657 		48,550 -3.4% 14.86 USD 721,657
2024-10-17 2024-10-15 PS Planned sale

Tanimoto Sarina

CHIEF MEDICAL OFFICER

Officer Large shareholder
50,000 -3.7%
14.88
USD 743,820 		50,000 -3.7% 14.88 USD 743,820
2024-10-17 2024-10-15 PS Planned sale

Tanimoto Sarina

CHIEF MEDICAL OFFICER

Officer Large shareholder
1,450 -0.1%
15.25
USD 22,118 		1,450 -0.1% 15.25 USD 22,118
2024-10-17 2024-10-15 PS Planned sale

Tanimoto Sarina

CHIEF MEDICAL OFFICER

Officer Large shareholder
48,550 -3.4%
14.86
USD 721,657 		48,550 -3.4% 14.86 USD 721,657
2024-10-10 2024-10-08 PS Planned sale

Tanimoto Sarina

CHIEF MEDICAL OFFICER

Officer Large shareholder
50,000 -3.6%
13.83
USD 691,390 		50,000 -3.6% 13.83 USD 691,390
2024-10-10 2024-10-08 PS Planned sale

Tanimoto Sarina

CHIEF MEDICAL OFFICER

Officer Large shareholder
50,000 -3.6%
13.83
USD 691,385 		50,000 -3.6% 13.83 USD 691,385
2024-10-10 2024-10-08 PS Planned sale

Lowenthal Richard E

PRESIDENT AND CEO

Executive Director Large shareholder
50,000 -3.6%
13.83
USD 691,390 		50,000 -3.6% 13.83 USD 691,390
2024-10-10 2024-10-08 PS Planned sale

Lowenthal Richard E

PRESIDENT AND CEO

Executive Director Large shareholder
50,000 -3.6%
13.83
USD 691,385 		50,000 -3.6% 13.83 USD 691,385
2024-09-19 2024-09-18 PS Planned sale

Karas Eric

Chief Commercial Officer

Officer
10,000 -63.7%
14.00
USD 140,000 		10,000 -63.7% 14.00 USD 140,000
2024-09-19 2024-09-17 PS Planned sale

Tanimoto Sarina

CHIEF MEDICAL OFFICER

Officer Large shareholder
50,000 -3.5%
12.93
USD 646,680 		50,000 -3.5% 12.93 USD 646,680
2024-09-19 2024-09-17 PS Planned sale

Tanimoto Sarina

CHIEF MEDICAL OFFICER

Officer Large shareholder
50,000 -3.3%
12.93
USD 646,525 		50,000 -3.3% 12.93 USD 646,525
2024-09-19 2024-09-17 PS Planned sale

Lowenthal Richard E

PRESIDENT AND CEO

Executive Director Large shareholder
50,000 -3.5%
12.93
USD 646,680 		50,000 -3.5% 12.93 USD 646,680
2024-09-19 2024-09-17 PS Planned sale

Lowenthal Richard E

PRESIDENT AND CEO

Executive Director Large shareholder
50,000 -3.3%
12.93
USD 646,525 		50,000 -3.3% 12.93 USD 646,525
2024-09-12 2024-09-10 PS Planned sale

Lowenthal Richard E

PRESIDENT AND CEO

Executive Director Large shareholder
50,000 -3.3%
11.50
USD 574,910 		50,000 -3.3% 11.50 USD 574,910
2024-09-12 2024-09-10 PS Planned sale

Lowenthal Richard E

PRESIDENT AND CEO

Executive Director Large shareholder
50,000 -3.5%
11.50
USD 574,865 		50,000 -3.5% 11.50 USD 574,865
2024-09-12 2024-09-10 PS Planned sale

Tanimoto Sarina

CHIEF MEDICAL OFFICER

Officer Large shareholder
50,000 -3.3%
11.50
USD 574,910 		50,000 -3.3% 11.50 USD 574,910
2024-09-12 2024-09-10 PS Planned sale

Tanimoto Sarina

CHIEF MEDICAL OFFICER

Officer Large shareholder
50,000 -3.5%
11.50
USD 574,865 		50,000 -3.5% 11.50 USD 574,865
2024-08-28 2024-08-26 S Sale

Thompson Peter A.

Non-Executive Director
83,695 -100.0%
13.00
USD 1,088,035 		83,695 -100.0% 13.00 USD 1,088,035
2024-08-28 2024-08-26 S Sale

ORBIMED ADVISORS LLC

Non-Executive Director
83,695 -100.0%
13.00
USD 1,088,035 		83,695 -100.0% 13.00 USD 1,088,035
2024-08-23 2024-08-23 S Sale

ORBIMED ADVISORS LLC

Non-Executive Director
69,500 -45.4%
13.03
USD 905,585 		69,500 -45.4% 13.03 USD 905,585
2024-08-23 2024-08-23 S Sale

Thompson Peter A.

Non-Executive Director
69,500 -45.4%
13.03
USD 905,585 		69,500 -45.4% 13.03 USD 905,585
2024-08-23 2024-08-22 S Sale

ORBIMED ADVISORS LLC

Non-Executive Director
391,482 -71.9%
12.94
USD 5,065,777 		391,482 -71.9% 12.94 USD 5,065,777
2024-08-23 2024-08-22 S Sale

Thompson Peter A.

Non-Executive Director
391,482 -71.9%
12.94
USD 5,065,777 		391,482 -71.9% 12.94 USD 5,065,777
2024-08-23 2024-08-21 S Sale

ORBIMED ADVISORS LLC

Non-Executive Director
13,300 -2.4%
14.61
USD 194,313 		13,300 -2.4% 14.61 USD 194,313